Lactococcus lactis expressing IL-27: A potential therapeutic for inflammatory bowel disease

被引：0
|
作者：
Hanson, Miranda L. [1 ]
Nixon, Julie A. [1 ]
Li, Wenqing [1 ]
Felber, Barbara K. [2 ]
Anver, Miriam R. [3 ]
Steidler, Lothar [4 ]
Durum, Scott K. [1 ]
机构：
[1] NCI, Mol Immunoregulat Lab, Canc Inflammat Program, Ctr Canc Res, Frederick, MD 21701 USA
[2] NCI, Human Retrovirus Pathogenesis Sect, Vaccine Branch, Ctr Canc Res, Frederick, MD 21701 USA
[3] NCI, LASP, SAIC, Ctr Canc Res, Frederick, MD 21701 USA
[4] ActoGenix NV, Zwijnaarde, Belgium
来源：
CYTOKINE | 2010年 / 52卷 / 1-2期
关键词：
D O I：
10.1016/j.cyto.2010.07.099
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：22 / 23
页数：2
相关论文
共 50 条
  • [1] Lactococcus lactis expressing IL-27: A potential therapeutic for inflammatory bowel disease
    Hanson, Miranda L.
    Hixon, Julie A.
    Li, Wenqing
    Felber, Barbara K.
    Anver, Miriam R.
    Stewart, Charles A.
    Shen, Wei
    McLean, Mairi
    Rottiers, Pieter
    Steidler, Lothar
    Durum, Scott K.
    CYTOKINE, 2013, 63 (03) : 269 - 269
  • [2] LACTOCOCCUS LACTIS EXPRESSING IL-27: A POTENTIAL THERAPEUTIC FOR INFLAMMATORY BOWEL DISEASE
    Hanson, M. L.
    Hixon, J. A.
    Li, W.
    Felber, B. K.
    Anver, M. R.
    Stewart, C. A.
    Shen, W.
    Steidler, L.
    Durum, S. K.
    INFLAMMATION RESEARCH, 2012, 61 : S15 - S16
  • [3] LACTOCOCCUS LACTIS EXPRESSING IL-27: A POTENTIAL THERAPEUTIC FOR INFLAMMATORY BOWEL DISEASE (IBD)
    Hanson, Miranda
    Hixon, Julie
    Li, Wenqing
    Felber, Barbara
    Anver, Miriam
    Steidler, Lothar
    Durum, Scott
    INFLAMMATION RESEARCH, 2010, 59 : S301 - S301
  • [4] Lactococcus lactis expressing IL-27: Therapeutic promise in inflammatory bowel disease
    Durum, Scott K.
    Li, Wen Qing
    Hixon, Julie A.
    Felber, Barbara
    Steidler, Lothar
    Hanson, Miranda L.
    CYTOKINE, 2010, 52 (1-2) : 11 - 11
  • [5] Therapeutic potential of IL-27 for inflammatory and autoimmune diseases
    Miyazaki, Yoshiyuki
    Nakashima, Hitoshi
    Yoshida, Hiroki
    CYTOKINE, 2008, 43 (03) : 255 - 255
  • [6] Role of Interleukin 27 (IL-27) in the Colonic Mucosa of Patients With Inflammatory Bowel Disease
    Yamamoto-Furusho, Jesus K.
    Fonseca-Camarillo, Gabriela
    Furuzawa-Carballeda, Janette
    GASTROENTEROLOGY, 2015, 148 (04) : S692 - S692
  • [7] Therapeutic potential of IL-27 in multiple sclerosis?
    Fitzgerald, Denise C.
    Rostami, Abdolmohamad
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (02) : 149 - 160
  • [8] Role of Interleukin 27 (IL-27) in the Colonic Mucosa of Patients with Inflammatory Bowel Disease.
    Fonseca Camarillo, G.
    Janette, F. -C.
    Jesus Kazuo, Y. F.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S88 - S89
  • [9] INTRA-LUMINAL INTERLEUKIN (IL)-27 IS A POTENTIAL FUTURE THERAPEUTIC FOR INFLAMMATORY BOWEL DISEASE
    McLean, M. H.
    Hanson, M. L.
    Gold, B.
    Golubeva, Y.
    Anver, M. R.
    Wu, X.
    Sun, D.
    Steidler, L.
    Durum, S. K.
    GUT, 2014, 63 : A84 - A84
  • [10] Therapeutic potential of IL-27 in systemic lupus erythematosus
    Pan, Hai-Feng
    Tao, Jin-Hui
    Ye, Dong-Qing
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2010, 14 (05) : 479 - 484
12345